Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

WPD Pharmaceuticals Inc (F: 8SV1)

 
8SV1 Technical Analysis
5
As on 11th Jul 2022 8SV1 STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.12 & Strong Sell for SHORT-TERM with Stoploss of 0.22 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

8SV1STOCK Price

Open 0.01 Change Price %
High 0.01 1 Day -0.01 -50.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month -0.03 -75.00
Volume N/A 1 Year -0.24 -96.00
52 Week High 0.29 | 52 Week Low 0.01
 
F Germany Most Active Stocks
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
TOE 0.02 0.00%
 
F Germany Top Gainers Stocks
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
8S3B 1.73 620.83%
8S3B 1.73 620.83%
SY7P 0.07 600.00%
P9F1 1.75 326.83%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
AETG 0.25 -91.61%
AETG 0.25 -91.61%
 
 
8SV1
Daily Charts		 8SV1
Intraday Charts		 Whats New @
Bazaartrend		 8SV1
Free Analysis
 
8SV1 Important Levels Intraday
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
 
8SV1 Forecast May 2024
Share
4th UP Forecast0.2
3rd UP Forecast0.14
2nd UP Forecast0.1
1st UP Forecast0.06
1st DOWN Forecast-0.04
2nd DOWN Forecast-0.08
3rd DOWN Forecast-0.12
4th DOWN Forecast-0.18
 
8SV1 Weekly Forecast
4th UP Forecast0.09
3rd UP Forecast0.06
2nd UP Forecast0.05
1st UP Forecast0.03
1st DOWN Forecast-0.01
2nd DOWN Forecast-0.03
3rd DOWN Forecast-0.04
4th DOWN Forecast-0.07
 
8SV1 Forecast2024
4th UP Forecast0.55
3rd UP Forecast0.38
2nd UP Forecast0.27
1st UP Forecast0.16
1st DOWN Forecast-0.14
2nd DOWN Forecast-0.25
3rd DOWN Forecast-0.36
4th DOWN Forecast-0.53
 
 
8SV1 Other Details
Segment EQ
Market Capital 7728597.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
8SV1 Address
8SV1
 
8SV1 Latest News
 
Your Comments and Response on WPD Pharmaceuticals Inc
 
8SV1 Business Profile
WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious diseases. Its drug development pipeline includes WPD101 to treat brain cancers, including glioblastoma that is in the pre-clinical trial; WPD102 to treat Uval Melanoma, which is in the pre-clinical trial; Berubicin for the treatment of glioblastoma that us in phase 1 clinical trial; and WP1066 to treat central nervous system tumors, pancreatic cancer, and ocular tumors, which is in phase 1 clinical trial. The company's drug development pipeline also includes WP1732 for the treatment of pancreatic cancer; WP1220 to treat cutaneous T-cell lymphoma; WPD103 for the treatment of glioblastoma multiforme that is in the pre-clinical trial; and Annamycin to treat acute myeloid leukemia (AML) and metastasis to lungs, which is in Phase I/II clinical trials in AML. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada. Address: 789 West Pender Street, Vancouver, BC, Canada, V6C 1H2
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service